Q
ELV icon

QVR’s Elevance Health ELV Stock Holding History

QVR’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$103K – 67
2022
Q4 		$103K Sell
200
-700
-78% -$355K 0.01% 142
2022
Q3 		$408K Sell
900
-900
-50% -$431K 0.03% 257
2022
Q2 		$869K Sell
1,800
-6,700
-79% -$3.31M 0.06% 202
2022
Q1 		$4.17M Buy
+8,500
New +$3.89M 0.16% 134
2021
Q4 		– Sell
-2,400
Closed -$896K – 118
2021
Q3 		$896K Buy
2,400
+1,200
+100% +$456K 0.06% 210
2021
Q2 		$457K Buy
1,200
+800
+200% +$306K 0.05% 192
2021
Q1 		$144K Buy
+400
New +$129K 0.01% 164

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

QVR's ELV Position: Q2 2024 in Review

QVR sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 444 shares — an estimated $230K sold.

QVR first reported a position in ELV in Q3 2021 and held it in 4 quarters. The position peaked at $1.05M in Q3 2022. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • QVR reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • QVR sold 444 Elevance Health shares in Q2 2024, an estimated $230K.
  • QVR first reported a position in Elevance Health in Q3 2021 and held it in 4 quarters.
  • QVR's Elevance Health position peaked at $1.05M in Q3 2022.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on QVR's 13F filing for Q2 2024, filed 29 Jul 2024.